Global Blood TherapeuticsGBT
13F holders, Q3 2024 (September 30)1holders
0new positions
0sold out
$68.00avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Global Blood Therapeutics Inc. (GBT) in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holder was Huntington National Bank ($68).
- Company
- Global Blood Therapeutics Inc.
- CUSIP
- 37890U108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Huntington National Bank | 0.00% | No change | 1 | $68 |
"% of holder's portfolio" is GBT's weight in each manager's 13F, not the share of Global Blood Therapeutics Inc. the manager owns.